Capshine Tablet
Marketer
Symbion Lifescience
Salt Composition
Capecitabine (500mg)
Overview Capshine Tablet
Oncasin tablets are indicated for the management of breast, colorectal, and rectal cancers. Additional applications may be determined by a physician. It's administered as part of a chemotherapy regimen, either independently or in conjunction with other medications. Oncasin should be ingested with food, within 30 minutes post-meal. Dosage and frequency are physician-determined, contingent on the specific condition being treated and may be adjusted. Strict adherence to the prescribed regimen is crucial; improper usage or overdosage may result in severe adverse effects. Therapeutic benefits may not be apparent for several weeks or months; discontinuation should only occur under medical supervision. Frequent side effects encompass nausea, vomiting, weakness, abdominal discomfort, and diarrhea. A reduction in blood cell counts (specifically white blood cells), increasing infection vulnerability, is possible. Regular blood work monitoring, including white blood cell count, liver function, heart function, and uric acid levels, is mandated. Prior to commencing treatment, disclose any pre-existing renal or hepatic conditions, or concurrent use of antimicrobial medications. Potential drug interactions necessitate a comprehensive disclosure of all medications to your physician. This medication is contraindicated during pregnancy and lactation. Employing effective contraception for both partners throughout the treatment duration is essential to prevent conception.
Uses of Capshine Tablet
Carcinoma of the mammary gland | Colorectal cancer
Major Benefits of Capshine Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Capshine Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Capshine Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Capshine Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Capshine Tablets should be administered with food.
How Capshine Tablet works:
Capshine tablets function as an antineoplastic agent. Metabolic processes transform the drug into 5-fluorouracil, which inhibits the production of nucleic acids (RNA and DNA) within cancerous cells. This disruption of cellular replication leads to decelerated tumor growth and ultimately, cellular death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Capshine Tablet may be unsafe; physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Capshine tablets during pregnancy is contraindicated due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Lactation and Capshine Tablet are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Taking Capshine Tablet may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving is discouraged if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Capshine Tablets, as dosage modification may be necessary. Consult your physician for guidance. Capshine Tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Capshine Tablet, potentially requiring dosage modification under medical supervision. Capshine Tablet is contraindicated for individuals with severe renal dysfunction.
What if you forget to take Capshine Tablet :
NA
Facts to Know About Capshine Tablet
Label | Value |
---|---|
Chemical Category | Modified Deoxycytidine |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Behavior Class | Metabolic inhibitors |